GRCE Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Grace Therapeutics, Inc (GRCE) Moving Averages Convergence Divergence (MACD) indicator is -0.116, suggesting GRCE is Strong Sell.

Grace Therapeutics, Inc (GRCE) 20-Day simple moving average is 2.325, while Grace Therapeutics, Inc (GRCE) share price is $2.31, making it Sell.

Grace Therapeutics, Inc (GRCE) 60-Day simple moving average is 3.19, while Grace Therapeutics, Inc (GRCE) share price is $2.31, making it Sell.

Technical Analysis for GRCE

Technical Sentiment Analysis for Grace Therapeutics, Inc (GRCE) As of 2026-06-10, Grace Therapeutics, Inc (GRCE) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 10 technical signals, shows that 1 indicators are flashing buy, while 9 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for GRCE stands at 41.756, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.116, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 32.675 and the Commodity Channel Index (CCI) at -8.09 further confirm a -0.02 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, GRCE is trading below its 60-day moving average of $3.19 and below its 200-day long-term moving average of $3.326. Key price levels to watch include the immediate resistance at $2.671 and strong support at $2.221. A break above $2.671 could signal a bull continuation, while falling below $2.221 may test the next Fibonacci floor at $2.016.

Grace Therapeutics, Inc (GRCE) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	1.771	2.016	2.221	2.466	2.671	2.916	3.121
Fibonacci	2.016	2.188	2.294	2.466	2.638	2.744	2.916

Grace Therapeutics, Inc (GRCE) Technical Indicators

2026-06-10

Name	Value
RSI_14	41.756
STOCHk_14_3_3	32.675
STOCHd_14_3_3	35.479
CCI_20	-8.09
AO_5_34	0.0269
MOM_10	-0.02
MACD_12_26_9	-0.116

Grace Therapeutics, Inc (GRCE) Relative Strength Index (RSI) is 41.756, creating a Neutral signal.

Grace Therapeutics, Inc (GRCE) Stochastic Oscillator is 32.675, creating a Neutral signal.

Grace Therapeutics, Inc (GRCE) Stochastic RSI is 35.479, creating a Neutral signal.

Grace Therapeutics, Inc (GRCE) Commodity Channel Index (CCI) is -8.09, creating a Neutral signal.

Grace Therapeutics, Inc (GRCE) Awesome Oscillator is 0.0269, creating a Buy signal.

Grace Therapeutics, Inc (GRCE) Momentum is -0.02, creating a Sell signal.

Grace Therapeutics, Inc (GRCE) MACD is -0.116, creating a Sell signal.

Grace Therapeutics, Inc (GRCE) Moving Average

2026-06-10

Period	Simple	Signal
MA_5	2.326	Sell
MA_10	2.427	Sell
MA_20	2.325	Sell
MA_60	3.19	Sell
MA_200	3.326	Sell
MA_250	3.282	Sell

Grace Therapeutics, Inc (GRCE) 5-Day simple moving average is 2.326, while Grace Therapeutics, Inc (GRCE) share price is $2.31, making it a Sell.

Grace Therapeutics, Inc (GRCE) 10-Day simple moving average is 2.427, while Grace Therapeutics, Inc (GRCE) share price is $2.31, making it a Sell.

Grace Therapeutics, Inc (GRCE) 20-Day simple moving average is 2.325, while Grace Therapeutics, Inc (GRCE) share price is $2.31, making it a Sell.

Grace Therapeutics, Inc (GRCE) 60-Day simple moving average is 3.19, while Grace Therapeutics, Inc (GRCE) share price is $2.31, making it a Sell.

Grace Therapeutics, Inc (GRCE) 200-Day simple moving average is 3.326, while Grace Therapeutics, Inc (GRCE) share price is $2.31, making it a Sell.

Grace Therapeutics, Inc (GRCE) 250-Day simple moving average is 3.282, while Grace Therapeutics, Inc (GRCE) share price is $2.31, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for GRCE?

The overall technical consensus for Grace Therapeutics, Inc (GRCE) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 1 buy signals and 3 sell signals.

What are the key support and resistance levels for Grace Therapeutics, Inc (GRCE) today?

Based on pivot point calculations, Grace Therapeutics, Inc (GRCE) has an immediate support level at 2.221 and a major resistance level at 2.671. Traders also monitor the pivot point at 2.466 to determine the intraday trend direction.

Is Grace Therapeutics, Inc (GRCE) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Grace Therapeutics, Inc (GRCE) is currently 41.756. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Grace Therapeutics, Inc (GRCE)?

Grace Therapeutics, Inc (GRCE) Moving Averages Convergence Divergence (MACD) indicator is -0.116, suggesting GRCE is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Grace Therapeutics, Inc.

How is Grace Therapeutics, Inc (GRCE) performing relative to its 200-day moving average?

Grace Therapeutics, Inc (GRCE) is currently trading at $2.31, which is below its 200-day simple moving average of 3.326. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.